Hemostemix Inc V.HEM

IS THE DAWN OF THE STEM CELL REVOLUTION FINALLY HERE?

[Pimpovish]

Unlike the crypto, psychedelics or cannabis space, this stock is grounded in a pharma segment with less volatility and more sequential value escalation. The most impressive aspect of this company is the IP. 10 years of data and 91 patents in the autologous stem cell niche gives them leadership status. I dont want to sound  presumptuous and say this stock is going to do a near term triple and by no means will it stop there.
However, I'm going to go out on a limb and be presumptuous. I think investors are starting to wake up to the realization that a previous negative scenario has done a front roll into a very positive outcome. Lucky were the buyers that bought 1-2 cents. They had Nostradamus like foresight. The reality is the stock still remains severely undervalued and consequently is still a screaming buy. I fully expect to see a frenzy of buying pressure pre-rollback. My call is 4-5 cents. This is an unusual rollback as it is being done on strength. The IP's value will soon be magnified with midpoint statistical results. I can transparently say big buying is coming into this stock. Frankly, its already started. A couple of whales have come in and they are now communicating with their respective networks. Look for a rising share price and attention grabbing volume over the next 2 trading sessions. Anyone that wants to wait post rollback to buy is either going to be very smart or very wrong. The 20:1 consolidation is going to make it difficult to amass size. Further, it would be logical to think the company has plans to bring in IR and PR to generate awareness. They will be well funded to do so. Another wildcard to consider is the possibility of a large Pharma partner coming to the table. Another wildcard possibility is the potential buyout of the company once they obtain their midpoint results. There is massive risk/reward with Hemostemix. Maybe the best I've seen in years. These are all expressed opinions but as a large investor, I'm loving my odds on a big ROI. 

Scientific experts predicted that stem cells will bring a paradigm shift in medicine. Clinicians already use adult stem cells to treat blood and immune disorders.

Many studies have focused on a particular type: induced pluripotent stem cells (iPSC’s), these cells can be converted into any kind of cell in the body. If you do a search for  “the promise of stem cells,”  200,000 items will appear, involving diabetes, neurodegenerative disorders, and other medical conditions.

www.medadvisor.co › news-blog › i...

Web results

Is the Dawn of the Stem Cell Revolution Finally ... - MedAdvisor

Dec. 8, 2020 — Clinicians already use adult stem cells to treat blood and immune disorders. Many studies have focused on a particular type: .
 

[22Ontarioboy222]

Great Post. I've sent you a private message

[HigherBuyer]

Great post. Thank you for sharing. Amazing to see the market wake up to the potential here. A successful Phase 3 validation makes the valuation growth mind boggling. Phase 2 midpoint results will bring in the large institutions, and with pennyland a distant memory soon enough, global investors will also take notice. This stock is at a manor inflection point and your comments about whale positions

[Khumamayo]

REVERSE SPLIT 20-1 EOM